Articles Published in 2014

Zealand Pharma, Boehringer Ingelheim collaborate on novel peptide medicines

Wednesday, July 30, 2014 12:43 PM

Zealand Pharma, specializing in the discovery, design and development of peptide medicines, and Boehringer Ingelheim have announced a new global R&D collaboration. The collaboration covers a novel therapeutic peptide project from Zealand’s portfolio of preclinical programs. The aim is to develop novel medicines for improved treatment of cardio-metabolic diseases. The target is undisclosed.

More... »

WIRB Copernicus Group

PCI to acquire Penn Pharma

Wednesday, July 30, 2014 12:42 PM

Packaging Coordinators (PCI) has reached a definitive agreement to acquire Penn Pharmaceutical Services.

More... »

CRF Health eCOA webinar series

Report: Global HIV prevention research down $50M in 2013

Wednesday, July 30, 2014 12:40 PM

According to HIV Vaccines and Microbicides: Resource Tracking Working Group, in 2013 the reported funding for HIV prevention R&D declined by $50 million (4%) compared to 2012, after moderate  increases during the past five years in most HIV prevention R&D research areas, resulting in a total of $1.26 billion.

More... »

NIH programs to focus on emerging areas of science

Wednesday, July 30, 2014 12:40 PM

Scientific areas ripe for targeted investments in technology development and research to improve health are the focus of new programs of the NIH’s Common Fund. The programs include work to facilitate the study of how sugar modifications affect proteins, to understand the arrangement of DNA within cells in four dimensions and to enable the development of new therapies that allow control of organ function through manipulation of nerves.

More... »

Report: Increasing potential for in vitro diagnostics in drug development process

Wednesday, July 30, 2014 12:39 PM

Bionest Partners, a life science industry strategic consulting firm, has found an increased potential for in vitro diagnostics in the drug development process.

More... »

Cloud Pharmaceuticals receives $150,000 phase I grant from NSF SBIR

Wednesday, July 30, 2014 12:37 PM

Cloud Pharmaceuticals, a therapeutics company focused on cloud-based drug design and development, has been awarded a phase I grant from the National Science Foundation Small Business Innovation Research (NSF SBIR) program. The grant is valued at $150,000.

More... »

BioFusionary to complete reverse takeover of Continuation Investments

Wednesday, July 30, 2014 12:30 PM

Colorado-based BioFusionary, a medical technology company focused on developing a proprietary electromagnetic induction platform with aesthetic and surgical applications, has entered into an agreement under which BioFusionary will merge with Australia-based Continuation Investments in an all-stock transaction.

More... »

Amgen to cut up to 3,000 jobs, most in U.S., close facilities

Wednesday, July 30, 2014 11:42 AM

Amgen has announced a restructuring plan to invest in continuing innovation and the launch of its new pipeline molecules, while improving cost structure.

More... »

Report: Generics increase to more than 75% of all 2013 prescriptions in England, Wales

Monday, July 28, 2014 03:04 PM

Usage of generic medicines in England and Wales increased to more than three-quarters of all NHS prescriptions in 2013, according to the latest figures supplied by the Health and Social Care Information Center (HSCIC).

More... »

NIAID awards SRI International $49M to study new therapies for HIV and AIDS

Monday, July 28, 2014 03:02 PM

SRI International has been awarded a new $49 million, seven-year contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, to conduct preclinical development of potential therapies for HIV infection and AIDS. The contract supports the development of drugs to treat HIV and AIDS and the complications and opportunistic infections associated with the disease, as well as microbicides for preventing sexual transmission of HIV.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs